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OBJECTIVE — We conducted a retrospective cohort study assessing the prevalence and
clinicalandradiologicaloutcomeofremoteareasofbonemarrowedemaonmagneticresonance
imaging (MRI) in the feet of subjects with diabetes and neuropathic foot ulceration.
RESEARCH DESIGN AND METHODS — MRIs performed over 6 years looking for
osteomyelitis associated with neuropathic lesions were assessed for remote areas of signal
change.
RESULTS — Seventy MRI studies were assessed. Remote areas of signal change were present
in21(30%)subjects,involvedmidfootorhindfootin20subjects,wereassociatedwithyounger
age and renal replacement therapy, and did not predict future Charcot neuroarthropathy or
infectionatthatsite.RepeatMRIsin11subjectswithsuchareasfoundthatnonehadprogressed,
six had improved, and two had resolved; in 29 subjects without such areas, ﬁve had developed
new areas.
CONCLUSIONS — Bone marrow edema in the midfoot and hindfoot of subjects with dia-
betes and neuropathic lesions is common, often transient, and of unknown signiﬁcance.
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W
e have previously described the
value of magnetic resonance im-
aging (MRI) to assess for osteo-
myelitis in association with neuropathic
foot lesions in subjects with diabetes
whereby the MRI criteria for diagnosis re-
quire bone signal change to be in direct
contiguity with signal change in the soft
tissue adjacent to the area of ulceration
(1). We have often incidentally observed
hyperintensity on T2-weighted images,
consistent with bone marrow edema, re-
mote from the area of neuropathic ulcer-
ation (Fig. 1) that often involves the
midfoot and hindfoot and is usually not
associated with adjacent clinical or radio-
logical signs of infection, clinical signs
suggesting acute Charcot neuroarthropa-
thy, or pain. We performed a retrospec-
tive cohort study to assess the prevalence
of such remote areas of signal change and
their subsequent clinical and radiological
outcome.
RESEARCH DESIGN AND
METHODS— MRIs performed be-
tween February 2003 and January 2009
to look for osteomyelitis associated with
neuropathic foot lesions in subjects with
diabetes where Charcot neuroarthropa-
thy had not been suspected clinically
wereassessedbytwoindependentradiol-
ogists (a third adjudicated where neces-
sary) for the presence or absence of
remote areas of signal change and osteo-
myelitis. MRI acquisition was described
previously (1). Medical records were as-
sessedforthesubsequentdevelopmentof
both Charcot neuroarthropathy and clin-
ical infection associated with the remote
area of signal change. Repeat MRIs per-
formed in a subgroup (often to follow the
response of osteomyelitis to conservative
management) were also assessed.
Continuous variables with normal
andskeweddistributionsareexpressedas
means (SDs) and medians (interquartile
ranges), respectively. The unpaired t test
or Fisher exact test was used to compare
the continuous and categorical variables,
respectively, between two groups. Co-
hen’s kappa coefﬁcient was used to assess
inter-observer correlation. Analyses were
performed using the SigmaStat package
(Systat, San Jose, CA). Our Caldicott
Guardian established that approval of the
local research ethics committee was not
required for analysis of the outcome of
routineclinicalmanagementandthepub-
lication of anonymous data derived from
it.
RESULTS— Seventy MRI studies in
66 subjects were assessed; both feet had
been studied in 4 subjects. There were 66
forefoot and 4 hindfoot lesions. Age was
64(13)years;durationofdiabetes21(14)
years;A1C8.6(2.1)percent;8(12%)had
type 1 diabetes; and 13 (20%) were on
renal replacement therapy (hemodialysis
or renal transplantation).
Remoteareasofsignalchangeinbone
were present in 21 studies (30%). The
neuropathic lesion involved the forefoot
in 20 studies, and the remote areas of sig-
nal change involved the forefoot in 1
study, the midfoot in 14, the hindfoot in
3, the midfoot and hindfoot in 1, and the
ankle and midfoot in 1; in 1 study, the
neuropathic lesion and the remote area
both involved the hindfoot.
Osteomyelitis underlying the neuro-
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studies, reﬂecting the high pretest proba-
bility. Fifty-four of the 70 neuropathic le-
sions (77%) healed with conservative
management alone. Inter-observer corre-
lation for the detection of both remote ar-
eas of signal change (0.7) and
osteomyelitis (0.7) was high (2).
Subjects with remote areas of signal
change were younger (56 [13] vs. 67 [12]
years; P  0.001) and more likely to re-
quire renal replacement therapy (43 vs.
9%; P  0.002) but were not more likely
to have type 1 diabetes (24 vs. 7%; P 
0.098). Duration of diabetes, A1C, sex
distribution, and prevalence of concur-
rent osteomyelitis were not different.
Durationofobservationfollowingthe
index MRI was 13 (7–19) months (range
3–62).Ofthe21feetwithremoteareasof
signal change, none developed Charcot
neuroarthropathy clinically and none de-
veloped clinical infection associated with
that area. Charcot neuroarthropathy de-
veloped in one foot 19 months following
the index MRI, which had demonstrated
neither remote areas of signal change nor
osteomyelitis.
Repeat MRIs were assessed in 11 of
the 21 feet (52%) with remote areas of
signal change and in 29 of the 49 feet
(59%) without remote areas of signal
change on the index MRI. The interval
between index and repeat MRI was 6 (4–
14)monthsforthosewithremoteareasof
signal change and 3 (3–5) months for
those without. For those with remote ar-
eas of signal change, the areas had re-
solved in two subjects, improved in six,
andhadnotchangedinthree;innonehad
theyworsened.Forthosewithoutareasof
signal change, they were absent as before
in 24, but had developed in 5: involving
the midfoot in 1, the hindfoot in 3, and
the midfoot and hindfoot areas in 1.
CONCLUSIONS— Wereportforthe
ﬁrst time that remote areas of signal
changeonMRIconsistentwithbonemar-
row edema in the feet of subjects with
diabetesandneuropathiclesionsarecom-
mon, with a prevalence of 30%, and tend
to involve midfoot and hindfoot areas.
Theirclinicalsigniﬁcanceisunclear.They
arenotduetoredmarrowreplacement,as
the hyperintensity on T2-weighted imag-
ing was not associated with the reduction
in signal on T1-weighted imaging (3,4).
They were in the substance of bone so
could be consistent with Charcot neuro-
arthropathy; like others (4,5), we have
found MRI changes with Charcot to be
widespread and not limited to subchon-
dral areas. Although they did not predict
future clinical Charcot, all subjects had
had ofﬂoading of the neuropathic lesions
with appropriate orthoses as part of rou-
tine management, which may have inter-
rupted the progression to Charcot.
Furthermore Charcot is rare, so that the
failure to predict future clinical Charcot
may represent a type II error.
While it is unlikely that the areas rep-
resented infective foci, many subjects re-
ceived antibiotics. However, almost all
cases of diabetic foot osteomyelitis result
from the contiguous spread of infection
from adjacent tissue (6).
Other causes of bone marrow edema
identiﬁed by MRI and collectively re-
ferred to as bone marrow edema syn-
drome (7) are associated with pain and
include transient osteoporosis of the hip,
regional migratory osteoporosis, and re-
ﬂex sympathetic dystrophy. Pain was not
a feature in the current study, although
subjects were neuropathic.
Analysis of repeat MRI studies sug-
gests a situation whereby remote areas of
signal change improve or resolve in many
affectedindividuals,butsubsequentlyde-
velop in some previously unaffected
individuals.
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Figure 1—Sagittal T2 fat-saturated magnetic resonance image shows remote areas of signal
change in the talus and calcaneum (arrows).
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